Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders

Details for Australian Patent Application No. 2009288738 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Jones, Robert M.; Buzard, Daniel J.; Kawasaki, Andrew M.; Kim, Sun Hee; Thoresen, Lars; Lehmann, Juerg; Zhu, Xiuwen

Agent FB Rice

Pub. Number AU-A-2009288738

PCT Pub. Number WO2010/027431

Priority 61/269,519 24.06.09 US; 61/190,311 27.08.08 US

Filing date 26 August 2009

Wipo publication date 11 March 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/437 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/027431 Priority application(s): WO2010/027431

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009288740-Balanced sn-2 myristate-containing edible oil

2009288730-Compositions of PD-1 antagonists and methods of use